There are no availability problems with Goldshield Pharmaceuticals's Parnate (tranylcypromine) 10mg tablets. The company has requested that the following note in the British National Formulary, under tranylcypromine, is removed: "The future availability of Parnate is uncertain, prescribers should seek alternative treatment."